This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Human Immunodeficiency Virus
and you are
between 18 and 80
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to evaluate the virological efficacy of maintenance therapy with atazanavir with ritonavir combined with lamivudine in treatment experienced HIV positive patients with full and stable virological suppression.

Provided treatments

  • Drug: Atazanavir, ritonavir, lamivudine
Tris trial is registered with FDA with number: NCT01599364. The sponsor of the trial is Catholic University of the Sacred Heart and it is looking for 266 volunteers for the current phase.
Official trial title:
Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression